When someone applies for life insurance after losing weight on GLP-1 medications, underwriters see what looks like a healthy person with: Normal BMI Improved blood pressure Better cholesterol levels Lower HbA1c levels But here's the catch: Research from the landmark STEP 1 trial extension shows that participants regain approximately two-thirds of their prior weight loss within one year of stopping semaglutide (Wilding et al., 2022)
2017;11:CD012037
Both peptides are active, and your physician will fine-tune dosages based on your response, lab results, and progress toward your goals
While GLP-1 receptor agonists, like semaglutide (found in medications such as Wegovy and Ozempic), are associated with weight loss, individual responses can vary greatly
Qiu, L., Nho, YH., Seilheimer, R.L
Many patients find it helpful to mark their injection sites with a washable pen or use a simple chart to track their rotation pattern